Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Vivani Medical, Inc. is a biopharmaceutical company developing novel, ultra-long-acting drug implants. Leveraging its NanoPortal platform, the Company develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Its lead program, NPM-115... see more

Recent & Breaking News (NDAQ:VANI)

Second Sight’s Argus II Retinal Prosthesis Implanted in First Patient in Asia

Business Wire April 13, 2017

Research Reports Initiation on Medical Equipment Stocks -- Align, ResMed, Corindus, and Second Sight Medical Products

PR Newswire April 10, 2017

Second Sight Announces Dr. Robert Greenberg, Chairman, Inducted as a National Academy of Inventors Fellow

Business Wire April 6, 2017

Second Sight Medical Products, Inc. Announces Warrants Approved for Listing on Nasdaq With Trading Scheduled to Commence March 29 under Symbol “EYESW”

Business Wire March 27, 2017

15 Biggest Mid-Day Losers For Wednesday

Benzinga.com  March 22, 2017

Second Sight Reports Fourth Quarter and Year End 2016 Financial Results

Business Wire March 9, 2017

Second Sight Medical Products, Inc. Announces Completion of Oversubscribed Rights Offering

Business Wire March 9, 2017

Second Sight Appoints David Jacques as Vice President of Research and Development

Business Wire March 2, 2017

Second Sight to Discuss Fourth Quarter and Year-End 2016 Financial Results on March 9, 2017 Conference Call

Business Wire March 1, 2017

How These Medical Equipment Stocks are Faring? -- Varex Imaging, Second Sight Medical Products, Masimo, and Avinger

PR Newswire March 1, 2017

Second Sight Announces Professor Stanislao Rizzo Has Completed His 30th Implant of the Argus II Retinal Prosthesis

Business Wire February 21, 2017

25 Stocks Moving In Wednesday's Pre-Market Session

Benzinga.com  February 8, 2017

Second Sight Medical Products, Inc. Announces Record Date, Subscription Pricing, Expiration Date for Rights Offering and Effectiveness of Its Registration Statement

Business Wire February 6, 2017

Second Sight Announces Positive Reimbursement Renewal Decision in Germany

Business Wire February 2, 2017

Second Sight Medical Products, Inc. Announces Rights Offering

Business Wire January 9, 2017

UK Government Announces Funding for Second Sight’s Argus II “Bionic Eye”

Business Wire December 22, 2016

Le gouvernement britannique accorde le remboursement de l’« œil bionique » Argus II de Second Sight

Business Wire December 22, 2016

Second Sight to Present at the 9th Annual LD Micro Main Event

Accesswire November 22, 2016

Second Sight Announces Final CMS Hospital Outpatient Payment Rate for 2017 and Two New CPT Codes for Programming the Argus II Retinal Prosthesis System

PR Newswire Europe Non Regulatory November 3, 2016

Second Sight Reports Third Quarter 2016 Financial Results

Business Wire November 2, 2016